High expectations for science projects sharing €40m fund
The 24 successful projects include the development of a vaccine against the hospital-acquired infection methicillin-resistant staphylococcus (MRSA).
The awards range from €50,000 to €2.7m over four- to five-year periods. The money will support projects involving 200 researchers and 39 companies.
Lunchtime News
Newsletter
Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.



